Funding Rounds
Affectis Pharmaceuticals Series B (2005, $4M)
Affectis PharmaceuticalsDrugs developer for the treatment of neurodegenerative and neuroinflammatory diseases.
Summary
Stage: Series B
Raised Amount: $4.30M
Stage: Series B
Raised Amount: $4.30M
